
Venmax Drugs & Pharmaceuticals Ltd Falls to 52-Week Low of Rs 12.75 as Sell-Off Deepens
2026-09-17 14:35:06For the third consecutive session, Venmax Drugs & Pharmaceuticals Ltd has seen its share price decline sharply, culminating in a fresh 52-week low of Rs 12.75 on 17 Sep 2026. This marks a significant 44.28% drop over the past year, considerably underperforming the Sensex, which itself is down 10.02% over the same period.
Read full news article
Venmax Drugs & Pharmaceuticals Ltd Falls to 52-Week Low Amidst Prolonged Downtrend
2026-09-02 14:35:10For the third consecutive session, Venmax Drugs & Pharmaceuticals Ltd has declined, culminating in a fresh 52-week low on 2 Sep 2026, as the stock slipped 7.06%% intraday. This latest drop extends a year-long slide where the share price has halved, contrasting sharply with the broader market's more modest losses.
Read full news article
Venmax Drugs & Pharmaceuticals Ltd Falls to 52-Week Low of Rs 14.1 as Sell-Off Deepens
2026-08-21 12:05:08For the second consecutive session, Venmax Drugs & Pharmaceuticals Ltd has seen its share price decline further, hitting a fresh 52-week low of Rs 14.1 on 21 Aug 2026. This drop comes amid a broader market where the Sensex trades marginally higher, underscoring a stark divergence in performance.
Read full news article
Venmax Drugs & Pharmaceuticals Ltd Falls to 52-Week Low of Rs 15.56 as Sell-Off Deepens
2026-07-16 10:35:22A sustained decline has pushed Venmax Drugs & Pharmaceuticals Ltd to a fresh 52-week low of Rs 15.56 on 16 Jul 2026, marking a 34.78% drop over the past year and signalling persistent pressure despite some recent outperformance relative to its sector.
Read full news articleAnnouncement under Regulation 30 (LODR)-Scheme of Arrangement
08-Sep-2026 | Source : BSEVenmax Drugs and Pharmaceuticals Limited has informed the exchange about the update in respect of Scheme of Amalgamation of Hatri Pharma Private Limited (Amalgamating Company) with Venmax Drugs and Pharmaceuticals Limited ( Amalgamated Company).
Reg. 34 (1) Annual Report.
01-Sep-2026 | Source : BSESubmission of Annual Report for the Financial Year 2025-26 Pursuant to Regulation 34 and other relevant provisions of the SEBI (Listing Obligations & Disclosure Requirements) 2015.
Board Meeting Outcome for Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015.
31-Aug-2026 | Source : BSEPursuant to Regulation 30 of SEBI (Listing Obligation and Disclosure Requirement) Regulations 2015 we would like to inform you that a meeting of Board of Directors of was held today i.e August 31 2026 at the registered office of the Company.
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available









